Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

S6K1 is a Targetable Vulnerability in Tumors Exhibiting Plasticity and Therapy Resistance

International Journal of Biological Sciences(2024)10.7150/ijbs.96672Source: DataRank Database

S6K1 is a Targetable Vulnerability in Tumors Exhibiting Plasticity and Therapy Resistance is a research paper published in International Journal of Biological Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.66)OA: goldTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Ravshan Burikhanov ORCID,Vitaliy M. Sviripa ORCID,Sally R. Ellingson ORCID,Jieyun Jiang ORCID,Christian M. Gosser

Live enrichment

PubMed:39781466 OpenAlex:https://openalex.org/W4405256008

National Institutes of Health

Grant: 5R01CA237643-02

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

National Institutes of Health

Grant: 3P30CA177558-01S1

CTRP Supplement

National Institutes of Health

Grant: 5R01CA187273-04

Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin

FWCI

0.66

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://www.ijbs.com/v21p0454.pdf

publisherhttps://www.ijbs.com/v21p0454.pdf

publisherhttps://www.ijbs.com/v21p0454.htm

journalhttps://doi.org/10.7150/ijbs.96672

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39781466

Fields of Study

Protein Degradation and InhibitorsLung Cancer Treatments and MutationsPI3K/AKT/mTOR signaling in cancer03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsAntineoplastic AgentsHumansNeoplasmsDrug Resistance, NeoplasmXenograft Model Antitumor AssaysRibosomal Protein S6 Kinases, 70-kDaCell Line, TumorMice

Keywords

Vulnerability (computing)Resistance (ecology)BiologyMedicineComputer scienceComputer securityEcologyMiceDrug Resistance, NeoplasmCell Line, TumorNeoplasmsHumansRibosomal Protein S6 Kinases, 70-kDaAnimalsAntineoplastic AgentsXenograft Model Antitumor AssaysResearch Paper